Dario™ Blood Glucose Monitoring System - User Performance Evaluation
NCT ID: NCT02053584
Last Updated: 2021-12-21
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
230 participants
INTERVENTIONAL
2013-06-30
2013-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The participants will review the Dario user manual and guide and will be requested to operate the Dario BGMS and perform their own glucose blood test, after which they will be asked to complete a questionnaire. As reference the participants will be tested by professional caregivers both using the Dario BGMS and by YSI 2003.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dario BGMS
Dario™ Blood Glucose Meter
Each subject will undergo a finger prick and also provide a venous blood sample
YSI2003
Blood samples will be tested using YSI (gold standard) for comparison to evaluate accuracy.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dario™ Blood Glucose Meter
Each subject will undergo a finger prick and also provide a venous blood sample
YSI2003
Blood samples will be tested using YSI (gold standard) for comparison to evaluate accuracy.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Type 1 and Type 2 diabetes
Exclusion Criteria
* Investigator discretion
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
LabStyle Innovations Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Julio Vainstein, MD
Role: PRINCIPAL_INVESTIGATOR
Wolfson Medical Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CR-0002
Identifier Type: -
Identifier Source: org_study_id